| NCT03912064 |
A Phase 1 Trial of CD25/Treg-depleted DLI Plus Ipilimumab for Myeloid Disease Relapse After Matched-HCT |
https://ClinicalTrials.gov/show/NCT03912064 |
Recruiting |
Dana-Farber Cancer Institute |
2022-04-26 |
| NCT03397173 |
TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic Acid |
https://ClinicalTrials.gov/show/NCT03397173 |
Recruiting |
Case Comprehensive Cancer Center |
2020-10-31 |
| NCT03333486 |
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer |
https://ClinicalTrials.gov/show/NCT03333486 |
Recruiting |
Roswell Park Cancer Institute |
2022-09-06 |
| NCT03314974 |
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders |
https://ClinicalTrials.gov/show/NCT03314974 |
Recruiting |
Masonic Cancer Center, University of Minnesota |
2025-01-10 |
| NCT03289910 |
Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia |
https://ClinicalTrials.gov/show/NCT03289910 |
Recruiting |
National Cancer Institute (NCI) |
2021-06-01 |
| NCT03238248 |
Pevonedistat and Azacitidine in MDS or MDS/MPN Patients Who Fail Primary Therapy With DNA Methyl Transferase Inhibitors |
https://ClinicalTrials.gov/show/NCT03238248 |
Recruiting |
Vanderbilt-Ingram Cancer Center |
2022-07-31 |
| NCT03194542 |
A Safety and Efficacy Study to Evaluate Luspatercept in Subjects With Myeloproliferative Neoplasm-associated Myelofibrosis Who Have Anemia With and Without Red Blood Cell-transfusion Dependence |
https://ClinicalTrials.gov/show/NCT03194542 |
Recruiting |
Celgene |
2021-06-16 |
| NCT03149055 |
Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT) |
https://ClinicalTrials.gov/show/NCT03149055 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-05-31 |
| NCT03144687 |
A Study of Itacitinib in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Subjects With Myelofibrosis |
https://ClinicalTrials.gov/show/NCT03144687 |
Active, not recruiting |
Incyte Corporation |
2020-07-31 |
| NCT03140280 |
Hypomethylating Properties of Freeze-dried Black Raspberries (BRB) in Patients With Myelodysplastic Syndrome or Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN) |
https://ClinicalTrials.gov/show/NCT03140280 |
Active, not recruiting |
Medical College of Wisconsin |
2019-06-01 |
| NCT03128359 |
High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT03128359 |
Recruiting |
City of Hope Medical Center |
2021-01-31 |
| NCT03123588 |
Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272) |
https://ClinicalTrials.gov/show/NCT03123588 |
Recruiting |
Incyte Corporation |
2020-05-31 |
| NCT03075826 |
A Phase II Study of SGI-110 in Philadelphia-Negative Myeloproliferative Neoplasms |
https://ClinicalTrials.gov/show/NCT03075826 |
Active, not recruiting |
Weill Medical College of Cornell University |
2021-02-19 |
| NCT03072043 |
Phase 1b/2 Safety and Efficacy of APR-246 w/Azacitidine for tx of TP53 Mutant Myeloid Neoplasms |
https://ClinicalTrials.gov/show/NCT03072043 |
Active, not recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2020-06-30 |
| NCT03065400 |
PD-1 Inhibition in Advanced Myeloproliferative Neoplasms |
https://ClinicalTrials.gov/show/NCT03065400 |
Completed |
Icahn School of Medicine at Mount Sinai |
2020-05-28 |
| NCT03011372 |
A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - (FIGHT-203) |
https://ClinicalTrials.gov/show/NCT03011372 |
Recruiting |
Incyte Corporation |
2020-07-31 |
| NCT02960646 |
Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT02960646 |
Recruiting |
M.D. Anderson Cancer Center |
2020-11-30 |
| NCT02121418 |
Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm |
https://ClinicalTrials.gov/show/NCT02121418 |
Completed |
University of Washington |
2017-02-08 |
| NCT02861417 |
Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT02861417 |
Recruiting |
M.D. Anderson Cancer Center |
2021-08-31 |
| NCT02806375 |
PTCy and Ruxolitinib GVHD Prophylaxis in Myelofibrosis |
https://ClinicalTrials.gov/show/NCT02806375 |
Completed |
St. Petersburg State Pavlov Medical University |
2018-12-31 |
| NCT02728050 |
Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib Tosylate in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT02728050 |
Recruiting |
University of Washington |
2020-10-31 |
| NCT02727803 |
Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelodysplastic Syndrome, Leukemia, Lymphoma or Multiple Myeloma |
https://ClinicalTrials.gov/show/NCT02727803 |
Recruiting |
M.D. Anderson Cancer Center |
2020-05-19 |
| NCT02722668 |
UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep |
https://ClinicalTrials.gov/show/NCT02722668 |
Recruiting |
Masonic Cancer Center, University of Minnesota |
2028-05-31 |
| NCT02718300 |
A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis |
https://ClinicalTrials.gov/show/NCT02718300 |
Recruiting |
Incyte Corporation |
2021-01-31 |
| NCT02666950 |
WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT02666950 |
Completed |
Mayo Clinic |
2018-09-25 |
| NCT02639559 |
Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies |
https://ClinicalTrials.gov/show/NCT02639559 |
Active, not recruiting |
Washington University School of Medicine |
2018-04-12 |
| NCT02257138 |
Ruxolitinib Phosphate and Decitabine in Treating Patients With Relapsed or Refractory or Post Myeloproliferative Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT02257138 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2021-02-28 |
| NCT02566304 |
Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT02566304 |
Recruiting |
Thomas Jefferson University |
2020-07-23 |
| NCT02556931 |
Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies |
https://ClinicalTrials.gov/show/NCT02556931 |
Active, not recruiting |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2021-07-31 |
| NCT02521493 |
Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome |
https://ClinicalTrials.gov/show/NCT02521493 |
Recruiting |
Children’s Oncology Group |
2023-03-31 |
| NCT02506933 |
Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant |
https://ClinicalTrials.gov/show/NCT02506933 |
Active, not recruiting |
City of Hope Medical Center |
2018-10-31 |
| NCT02424968 |
CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma |
https://ClinicalTrials.gov/show/NCT02424968 |
Active, not recruiting |
Stanford University |
2020-07-31 |
| NCT02396134 |
Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT02396134 |
Recruiting |
City of Hope Medical Center |
2020-05-31 |
| NCT02393248 |
Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) |
https://ClinicalTrials.gov/show/NCT02393248 |
Recruiting |
Incyte Corporation |
2020-07-31 |
| NCT03386513 |
Study of IMGN632 in Patients With Relapse/Refractory AML, BPDCN, ALL, Other CD123+ Hem Malignancies |
https://ClinicalTrials.gov/show/NCT03386513 |
Recruiting |
ImmunoGen, Inc. |
2020-08-31 |
| NCT02320656 |
Predictive Clinical and Biological Parameters in Acute Leukemia, Myelodysplastic Syndromes and Myeloproliferative Disorders-HEMATO-BIO-IPC-2013-015 |
https://ClinicalTrials.gov/show/NCT02320656 |
Recruiting |
Institut Paoli-Calmettes |
2019-05-31 |
| NCT02311569 |
Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation |
https://ClinicalTrials.gov/show/NCT02311569 |
Completed |
Swiss Group for Clinical Cancer Research |
2016-12-31 |
| NCT02267278 |
Ruxolitinib and Pracinostat Combination Therapy for Patients With Myelofibrosis (MF) |
https://ClinicalTrials.gov/show/NCT02267278 |
Completed |
M.D. Anderson Cancer Center |
2018-06-01 |
| NCT02210858 |
Tipifarnib in Treating Patients With Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Undifferentiated Myeloproliferative Disorders |
https://ClinicalTrials.gov/show/NCT02210858 |
Completed |
National Cancer Institute (NCI) |
2004-11-12 |
| NCT02158858 |
A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis |
https://ClinicalTrials.gov/show/NCT02158858 |
Recruiting |
Constellation Pharmaceuticals |
2021-08-31 |
| NCT02129101 |
Azacitidine and Sonidegib or Decitabine in Treating Patients With Myeloid Malignancies |
https://ClinicalTrials.gov/show/NCT02129101 |
Completed |
Mayo Clinic |
2016-12-31 |
| NCT02125318 |
A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders |
https://ClinicalTrials.gov/show/NCT02125318 |
Completed |
Galena Biopharma, Inc. |
2016-05-31 |
| NCT02084563 |
Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms |
https://ClinicalTrials.gov/show/NCT02084563 |
Completed |
Hospital Israelita Albert Einstein |
2014-12-31 |
| NCT02076191 |
Study of Combination Ruxolitinib and Decitabine Treatment for Accelerated Phase MPN or Post-MPN AML |
https://ClinicalTrials.gov/show/NCT02076191 |
Completed |
Icahn School of Medicine at Mount Sinai |
2018-07-20 |
| NCT01305200 |
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT01305200 |
Completed |
Children’s Oncology Group |
2015-06-30 |
| NCT01273766 |
Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT01273766 |
Completed |
Wake Forest University Health Sciences |
2012-03-31 |
| NCT02029950 |
Pomalidomide After Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT02029950 |
Active, not recruiting |
National Cancer Institute (NCI) |
2020-07-04 |
| NCT01894477 |
Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01894477 |
Active, not recruiting |
Fred Hutchinson Cancer Research Center |
2017-01-09 |
| NCT01872819 |
Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay |
https://ClinicalTrials.gov/show/NCT01872819 |
Completed |
University of Washington |
2014-11-30 |
| NCT01866839 |
Preventing Stem Cell Transplant Complications With a Blood Separator Machine |
https://ClinicalTrials.gov/show/NCT01866839 |
Completed |
National Institutes of Health Clinical Center (CC) |
2018-05-23 |
| NCT01844765 |
Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients. |
https://ClinicalTrials.gov/show/NCT01844765 |
Active, not recruiting |
Novartis |
2016-06-01 |
| NCT01831232 |
Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes |
https://ClinicalTrials.gov/show/NCT01831232 |
Completed |
Fred Hutchinson Cancer Research Center |
2015-02-28 |
| NCT01816256 |
Screening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients With Philadelphia Negative Myeloproliferative Neoplasms |
https://ClinicalTrials.gov/show/NCT01816256 |
Completed |
University Health Network, Toronto |
2019-03-11 |
| NCT01789255 |
Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies |
https://ClinicalTrials.gov/show/NCT01789255 |
Completed |
National Cancer Institute (NCI) |
2014-03-31 |
| NCT01787552 |
A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF |
https://ClinicalTrials.gov/show/NCT01787552 |
Completed |
Novartis |
2018-04-10 |
| NCT01761968 |
Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative Neoplasms |
https://ClinicalTrials.gov/show/NCT01761968 |
Active, not recruiting |
Italfarmaco |
2022-06-30 |
| NCT01758042 |
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders |
https://ClinicalTrials.gov/show/NCT01758042 |
Recruiting |
Massachusetts General Hospital |
2019-07-31 |
| NCT01712308 |
Sotatercept in Treating Patients With Myeloproliferative Neoplasm-Associated Myelofibrosis or Anemia |
https://ClinicalTrials.gov/show/NCT01712308 |
Recruiting |
M.D. Anderson Cancer Center |
2020-02-28 |
| NCT01684150 |
A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusion, Multi-center Study of the Safety, Tolerability,PK & PD of EPZ-5676 in Treatment Relapsed/Refractory Patients With Leukemias Involving |
https://ClinicalTrials.gov/show/NCT01684150 |
Completed |
Epizyme, Inc. |
2015-11-30 |
| NCT01633372 |
An Open Label Study of Itacitinib Administered Orally in Patients With Myelofibrosis |
https://ClinicalTrials.gov/show/NCT01633372 |
Active, not recruiting |
Incyte Corporation |
2013-12-31 |
| NCT01594723 |
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms |
https://ClinicalTrials.gov/show/NCT01594723 |
Active, not recruiting |
Eli Lilly and Company |
2015-03-20 |
| NCT01572662 |
Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning |
https://ClinicalTrials.gov/show/NCT01572662 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-04-30 |
| NCT01529827 |
Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT01529827 |
Completed |
Roswell Park Cancer Institute |
2015-05-28 |
| NCT01527045 |
Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies |
https://ClinicalTrials.gov/show/NCT01527045 |
Completed |
Fred Hutchinson Cancer Research Center |
2018-10-31 |
| NCT01520220 |
Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms |
https://ClinicalTrials.gov/show/NCT01520220 |
Completed |
Eli Lilly and Company |
2015-06-26 |
| NCT01499147 |
Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT01499147 |
Completed |
University of Illinois at Chicago |
2013-05-31 |
| NCT01484015 |
Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia |
https://ClinicalTrials.gov/show/NCT01484015 |
Completed |
Wake Forest University Health Sciences |
2012-06-30 |
| NCT01444742 |
Clofarabine Plus Low-Dose Cytarabine for Patients With Higher-Risk Myelodysplastic Syndrome (MDS) |
https://ClinicalTrials.gov/show/NCT01444742 |
Completed |
M.D. Anderson Cancer Center |
2017-01-29 |
| NCT01413568 |
Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT01413568 |
Completed |
Polyphor Ltd. |
2015-11-30 |
| NCT01393509 |
The First-in-human Phase I Trial of PU-H71 in Patients With Advanced Malignancies |
https://ClinicalTrials.gov/show/NCT01393509 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2020-07-31 |
| NCT01392989 |
Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders |
https://ClinicalTrials.gov/show/NCT01392989 |
Completed |
Stanford University |
2016-06-07 |
| NCT01384513 |
A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies |
https://ClinicalTrials.gov/show/NCT01384513 |
Recruiting |
Thomas Jefferson University |
2020-12-31 |
| NCT01375140 |
Ruxolitinib and Lenalidomide for Patients With Myelofibrosis |
https://ClinicalTrials.gov/show/NCT01375140 |
Completed |
M.D. Anderson Cancer Center |
2018-09-05 |
| NCT01366612 |
PRO#1278: Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation |
https://ClinicalTrials.gov/show/NCT01366612 |
Active, not recruiting |
Hackensack Meridian Health |
2022-08-31 |
| NCT01348490 |
Ruxolitinib (INCB018424) in Participants With Primary Myelofibrosis (PMF), Post Essential Thrombocythemia-myelofibrosis and Post Polycythemia Vera-myelofibrosis (PPV-MF) |
https://ClinicalTrials.gov/show/NCT01348490 |
Completed |
Incyte Corporation |
2018-12-19 |
| NCT03878524 |
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial |
https://ClinicalTrials.gov/show/NCT03878524 |
Recruiting |
OHSU Knight Cancer Institute |
2022-02-27 |
| NCT04339400 |
A Study of TQ05105 Tablets in Subjects With Myeloproliferative Neoplasms |
https://ClinicalTrials.gov/show/NCT04339400 |
Recruiting |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
2020-12-31 |
| NCT04282187 |
Decitabine With Ruxolitinib or Fedratinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms |
https://ClinicalTrials.gov/show/NCT04282187 |
Recruiting |
University of Washington |
2024-11-11 |
| NCT04191187 |
Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT04191187 |
Recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2022-12-31 |
| NCT04156256 |
CD123-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT04156256 |
Recruiting |
iCell Gene Therapeutics |
2020-09-30 |
| NCT04113616 |
An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 Combined With Low-Dose Cytarabine (LDAC) or Decitabine in Patients With Acute Myeloid Leukemia (AML) |
https://ClinicalTrials.gov/show/NCT04113616 |
Recruiting |
Kartos Therapeutics, Inc. |
2023-12-15 |
| NCT04064060 |
A Study to Evaluate Long-term Safety in Subjects Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials |
https://ClinicalTrials.gov/show/NCT04064060 |
Recruiting |
Celgene |
2028-01-24 |
| NCT04060277 |
Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT04060277 |
Recruiting |
City of Hope Medical Center |
2022-07-22 |
| NCT04051307 |
Dual Vaccine Trial in Myeloproliferative Neoplasms |
https://ClinicalTrials.gov/show/NCT04051307 |
Recruiting |
Herlev Hospital |
2022-07-10 |
| NCT04022785 |
PLX51107 and Azacitidine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT04022785 |
Recruiting |
M.D. Anderson Cancer Center |
2022-12-31 |
| NCT03977103 |
Irradiation-based Myeloablative Conditioning Followed by Treg/Tcon Immunotherapy in HSCT |
https://ClinicalTrials.gov/show/NCT03977103 |
Recruiting |
University Of Perugia |
2023-02-28 |
| NCT03907436 |
The NUTRIENT Trial (NUTRitional Intervention Among myEloproliferative Neoplasms): Feasibility Phase |
https://ClinicalTrials.gov/show/NCT03907436 |
Completed |
University of California, Irvine |
2019-10-01 |
| NCT03878199 |
Ruxolitinib and Daunorubicin (CPX-351) in Treating Patients With Secondary Acute Myeloid Leukemia Transformed From Myeloproliferative Neoplasms |
https://ClinicalTrials.gov/show/NCT03878199 |
Recruiting |
OHSU Knight Cancer Institute |
2021-12-31 |
| NCT03869476 |
Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms. |
https://ClinicalTrials.gov/show/NCT03869476 |
Recruiting |
University Hospital, Angers |
2023-06-30 |
| NCT03862157 |
Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT03862157 |
Recruiting |
M.D. Anderson Cancer Center |
2024-01-01 |
| NCT03808805 |
Aprepitant Versus Hydroxyzine in Persistent Aquagenic Pruritus for Patients With Myeloproliferative Neoplasms |
https://ClinicalTrials.gov/show/NCT03808805 |
Recruiting |
University Hospital, Brest |
2020-09-01 |
| NCT03795779 |
CLL1-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT03795779 |
Recruiting |
iCell Gene Therapeutics |
2020-09-30 |
| NCT03734601 |
Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation |
https://ClinicalTrials.gov/show/NCT03734601 |
Active, not recruiting |
Stanford University |
2020-11-30 |
| NCT03726944 |
The Feasibility of Delivering Consumer-based Meditation Applications to Myeloproliferative Neoplasm Patients |
https://ClinicalTrials.gov/show/NCT03726944 |
Completed |
Arizona State University |
2018-04-02 |
| NCT03630991 |
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy |
https://ClinicalTrials.gov/show/NCT03630991 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-12-31 |
| NCT03622788 |
Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT03622788 |
Recruiting |
M.D. Anderson Cancer Center |
2021-07-01 |
| NCT03613532 |
Venetoclax Added to Fludarabine + Busulfan Prior to Transplant for AML, MDS, and MDS/MPN |
https://ClinicalTrials.gov/show/NCT03613532 |
Recruiting |
Dana-Farber Cancer Institute |
2020-10-01 |
| NCT03589729 |
Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers |
https://ClinicalTrials.gov/show/NCT03589729 |
Recruiting |
M.D. Anderson Cancer Center |
2020-12-31 |
| NCT03588078 |
Study of the Safety and Efficacy of APR-246 in Combination With Azacitidine |
https://ClinicalTrials.gov/show/NCT03588078 |
Active, not recruiting |
Groupe Francophone des Myelodysplasies |
2020-05-01 |
| NCT03566446 |
CALR Exon 9 Mutant Peptide Vaccine to Patients With CALR-mutant Myeloproliferative Neoplasms |
https://ClinicalTrials.gov/show/NCT03566446 |
Active, not recruiting |
Herlev Hospital |
2020-02-20 |
| NCT03560752 |
CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Blood Cancer Undergoing Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT03560752 |
Recruiting |
City of Hope Medical Center |
2021-03-18 |
| NCT03558607 |
The Role of Ruxolitinib in Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative Neoplasm |
https://ClinicalTrials.gov/show/NCT03558607 |
Recruiting |
Seoul National University Hospital |
2022-04-30 |
| NCT03519984 |
EphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refractory Acute Leukemia |
https://ClinicalTrials.gov/show/NCT03519984 |
Recruiting |
University of Southern California |
2020-05-09 |
| NCT03480360 |
Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators’ Expression |
https://ClinicalTrials.gov/show/NCT03480360 |
Recruiting |
Dartmouth-Hitchcock Medical Center |
2021-12-31 |
| NCT03471260 |
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Participants With IDH1 Mutated Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT03471260 |
Recruiting |
M.D. Anderson Cancer Center |
2021-09-30 |
| NCT03434730 |
Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation |
https://ClinicalTrials.gov/show/NCT03434730 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-02-07 |
| NCT01233921 |
Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT01233921 |
Completed |
Fred Hutchinson Cancer Research Center |
2012-07-31 |
| NCT01231919 |
MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia |
https://ClinicalTrials.gov/show/NCT01231919 |
Completed |
National Cancer Institute (NCI) |
2013-04-30 |
| NCT01231412 |
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT01231412 |
Completed |
Fred Hutchinson Cancer Research Center |
2016-10-08 |
| NCT01200498 |
Study of SB939 in Subjects With Myelofibrosis |
https://ClinicalTrials.gov/show/NCT01200498 |
Completed |
M.D. Anderson Cancer Center |
2012-11-30 |
| NCT01178281 |
Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence |
https://ClinicalTrials.gov/show/NCT01178281 |
Completed |
Celgene |
2013-01-01 |
| NCT01167166 |
Safety and Efficacy of 72-hour and 120-hour Infusion of Rigosertib in Acute Myeloid Leukemia (AML) and Acute Lymphoid Leukemia (ALL) |
https://ClinicalTrials.gov/show/NCT01167166 |
Completed |
Onconova Therapeutics, Inc. |
2013-12-31 |
| NCT01164163 |
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease |
https://ClinicalTrials.gov/show/NCT01164163 |
Completed |
Children’s Oncology Group |
2014-10-31 |
| NCT01134120 |
A Study in Myeloproliferative Disorders |
https://ClinicalTrials.gov/show/NCT01134120 |
Completed |
Eli Lilly and Company |
2014-04-30 |
| NCT01101880 |
Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm |
https://ClinicalTrials.gov/show/NCT01101880 |
Completed |
University of Washington |
2013-06-30 |
| NCT01093586 |
Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT01093586 |
Completed |
Case Comprehensive Cancer Center |
2015-12-31 |
| NCT01056614 |
Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies |
https://ClinicalTrials.gov/show/NCT01056614 |
Completed |
Fred Hutchinson Cancer Research Center |
2005-08-31 |
| NCT01045382 |
MSC and HSC Coinfusion in Mismatched Minitransplants |
https://ClinicalTrials.gov/show/NCT01045382 |
Recruiting |
University of Liege |
2021-07-31 |
| NCT00988715 |
Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00988715 |
Completed |
Fred Hutchinson Cancer Research Center |
2015-01-31 |
| NCT00952289 |
COntrolled MyeloFibrosis Study With ORal JAK Inhibitor Treatment: The COMFORT-I Trial |
https://ClinicalTrials.gov/show/NCT00952289 |
Completed |
Incyte Corporation |
2010-11-30 |
| NCT00951626 |
A Standardized Nursing Intervention Protocol for HCT Patients |
https://ClinicalTrials.gov/show/NCT00951626 |
Completed |
City of Hope Medical Center |
2011-09-30 |
| NCT00949364 |
Pomalidomide in Patients With Myeloproliferative Neoplasms in Fibrotic Stage |
https://ClinicalTrials.gov/show/NCT00949364 |
Completed |
University of Ulm |
2016-12-14 |
| NCT00935090 |
3’-Deoxy-3’-[18F] Fluorothymidine PET Imaging in Patients With Cancer |
https://ClinicalTrials.gov/show/NCT00935090 |
Recruiting |
Barbara Ann Karmanos Cancer Institute |
2021-04-30 |
| NCT00908167 |
Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT00908167 |
Completed |
St. Jude Children’s Research Hospital |
2015-06-30 |
| NCT00890747 |
Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy |
https://ClinicalTrials.gov/show/NCT00890747 |
Completed |
National Cancer Institute (NCI) |
2011-05-31 |
| NCT00858572 |
STA-9090 for Treatment of AML, CML, MDS and Myeloproliferative Disorders |
https://ClinicalTrials.gov/show/NCT00858572 |
Completed |
Synta Pharmaceuticals Corp. |
2011-05-31 |
| NCT00856388 |
Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders |
https://ClinicalTrials.gov/show/NCT00856388 |
Completed |
Roswell Park Cancer Institute |
2012-08-09 |
| NCT00823524 |
Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer |
https://ClinicalTrials.gov/show/NCT00823524 |
Completed |
Asan Medical Center |
2013-02-28 |
| NCT03192397 |
Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT03192397 |
Recruiting |
Roswell Park Cancer Institute |
2021-07-01 |
| NCT01951885 |
Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention |
https://ClinicalTrials.gov/show/NCT01951885 |
Recruiting |
Case Comprehensive Cancer Center |
2020-07-31 |
| NCT01787487 |
Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative Neoplasm |
https://ClinicalTrials.gov/show/NCT01787487 |
Recruiting |
M.D. Anderson Cancer Center |
2020-07-26 |
| NCT00806767 |
Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer |
https://ClinicalTrials.gov/show/NCT00806767 |
Completed |
National Cancer Institute (NCI) |
2011-05-31 |
| NCT01822509 |
Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT01822509 |
Active, not recruiting |
National Cancer Institute (NCI) |
2018-12-31 |
| NCT00003838 |
Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow |
https://ClinicalTrials.gov/show/NCT00003838 |
Completed |
National Institutes of Health Clinical Center (CC) |
2018-12-14 |
| NCT04103645 |
Intra-patient Dose Escalation Study to Investigate Safety and Feasibility of Vactosertib in Treating Anemic MPN Patients |
https://ClinicalTrials.gov/show/NCT04103645 |
Active, not recruiting |
Weill Medical College of Cornell University |
2022-09-30 |
| NCT04041050 |
A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Alone and in Combination With Ruxolitinib in Asian Adult Participants With Myeloproliferative Neoplasm |
https://ClinicalTrials.gov/show/NCT04041050 |
Recruiting |
AbbVie |
2022-07-31 |
| NCT03246906 |
Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation |
https://ClinicalTrials.gov/show/NCT03246906 |
Recruiting |
Fred Hutchinson Cancer Research Center |
2022-08-15 |
| NCT00787761 |
Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer |
https://ClinicalTrials.gov/show/NCT00787761 |
Completed |
Northside Hospital, Inc. |
2010-07-31 |
| NCT00782145 |
A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families |
https://ClinicalTrials.gov/show/NCT00782145 |
Completed |
Tufts Medical Center |
2011-06-30 |
| NCT00755040 |
Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder |
https://ClinicalTrials.gov/show/NCT00755040 |
Completed |
Vanderbilt-Ingram Cancer Center |
2014-12-31 |
| NCT00750009 |
Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial |
https://ClinicalTrials.gov/show/NCT00750009 |
Completed |
Case Comprehensive Cancer Center |
2012-12-31 |
| NCT00745550 |
A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis |
https://ClinicalTrials.gov/show/NCT00745550 |
Completed |
S*BIO |
2012-01-31 |
| NCT00723099 |
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00723099 |
Completed |
Fred Hutchinson Cancer Research Center |
2018-07-31 |
| NCT00719563 |
American Ginseng in Treating Patients With Fatigue Caused by Cancer |
https://ClinicalTrials.gov/show/NCT00719563 |
Completed |
Alliance for Clinical Trials in Oncology |
2011-08-31 |
| NCT00716911 |
Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00716911 |
Completed |
City of Hope Medical Center |
2007-07-31 |
| NCT00691015 |
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00691015 |
Completed |
Barbara Ann Karmanos Cancer Institute |
2014-04-30 |
| NCT00683046 |
T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT00683046 |
Completed |
University of Chicago |
2014-12-31 |
| NCT00669578 |
CC-4047 in Treating Patients With Myelofibrosis |
https://ClinicalTrials.gov/show/NCT00669578 |
Completed |
Mayo Clinic |
2010-07-07 |
| NCT00666211 |
Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain |
https://ClinicalTrials.gov/show/NCT00666211 |
Completed |
Vanderbilt-Ingram Cancer Center |
2010-01-31 |
| NCT00636909 |
Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders |
https://ClinicalTrials.gov/show/NCT00636909 |
Completed |
Beth Israel Deaconess Medical Center |
2006-03-31 |
| NCT00627666 |
Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer |
https://ClinicalTrials.gov/show/NCT00627666 |
Completed |
National Cancer Institute (NCI) |
2010-06-30 |
| NCT00624936 |
Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes |
https://ClinicalTrials.gov/show/NCT00624936 |
Completed |
Ohio State University Comprehensive Cancer Center |
2009-12-31 |
| NCT00611351 |
Busulfan, Cyclophosphamide, and Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00611351 |
Completed |
University of Nebraska |
2008-02-29 |
| NCT00606307 |
Phase IIA Study of the HDAC Inhibitor ITF2357 in Patients With JAK-2 V617F Positive Chronic Myeloproliferative Diseases |
https://ClinicalTrials.gov/show/NCT00606307 |
Completed |
Italfarmaco |
2008-12-31 |
| NCT00592046 |
A Phase I Trial of ZIO-101 in Hematologic Cancers |
https://ClinicalTrials.gov/show/NCT00592046 |
Completed |
Ziopharm |
2008-06-30 |
| NCT00589563 |
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer |
https://ClinicalTrials.gov/show/NCT00589563 |
Completed |
City of Hope Medical Center |
2012-02-29 |
| NCT00588991 |
Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders |
https://ClinicalTrials.gov/show/NCT00588991 |
Active, not recruiting |
National Cancer Institute (NCI) |
2014-02-01 |
| NCT00588809 |
Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT00588809 |
Completed |
National Cancer Institute (NCI) |
2012-04-30 |
| NCT00588666 |
Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma |
https://ClinicalTrials.gov/show/NCT00588666 |
Completed |
Memorial Sloan Kettering Cancer Center |
2011-12-31 |
| NCT00544115 |
Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders |
https://ClinicalTrials.gov/show/NCT00544115 |
Active, not recruiting |
City of Hope Medical Center |
2019-11-30 |
| NCT00539695 |
Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD |
https://ClinicalTrials.gov/show/NCT00539695 |
Completed |
Baylor College of Medicine |
2013-04-30 |
| NCT00533923 |
Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders |
https://ClinicalTrials.gov/show/NCT00533923 |
Completed |
Beth Israel Deaconess Medical Center |
2007-01-31 |
| NCT00530218 |
Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant |
https://ClinicalTrials.gov/show/NCT00530218 |
Completed |
City of Hope Medical Center |
2010-02-28 |
| NCT00516503 |
Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer |
https://ClinicalTrials.gov/show/NCT00516503 |
Completed |
Alliance for Clinical Trials in Oncology |
2009-04-30 |
| NCT00516152 |
Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT |
https://ClinicalTrials.gov/show/NCT00516152 |
Completed |
University of California, San Francisco |
NA |
| NCT00513474 |
Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00513474 |
Completed |
Massachusetts General Hospital |
2013-02-12 |
| NCT00489203 |
Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00489203 |
Completed |
Fred Hutchinson Cancer Research Center |
2010-11-30 |
| NCT00462605 |
MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT00462605 |
Completed |
National Cancer Institute (NCI) |
2011-03-31 |
| NCT00453206 |
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases |
https://ClinicalTrials.gov/show/NCT00453206 |
Completed |
Wake Forest University Health Sciences |
2014-02-28 |
| NCT00452023 |
Pegasys® in Patients With Myeloproliferative Diseases |
https://ClinicalTrials.gov/show/NCT00452023 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-12-31 |
| NCT00448357 |
Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen |
https://ClinicalTrials.gov/show/NCT00448357 |
Completed |
UNC Lineberger Comprehensive Cancer Center |
2015-11-30 |
| NCT00448201 |
Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease |
https://ClinicalTrials.gov/show/NCT00448201 |
Completed |
UNC Lineberger Comprehensive Cancer Center |
2011-01-11 |
| NCT00445900 |
Thalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid Metaplasia |
https://ClinicalTrials.gov/show/NCT00445900 |
Completed |
Mayo Clinic |
2006-10-31 |
| NCT00438958 |
Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases |
https://ClinicalTrials.gov/show/NCT00438958 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00437086 |
Bortezomib in Treating Patients With Advanced Myeloproliferative Disorders |
https://ClinicalTrials.gov/show/NCT00437086 |
Completed |
Mayo Clinic |
2008-11-30 |
| NCT00425477 |
Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT00425477 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2016-09-30 |
| NCT00424242 |
Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases |
https://ClinicalTrials.gov/show/NCT00424242 |
Active, not recruiting |
Northwestern University |
2020-03-31 |
| NCT00410657 |
Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00410657 |
Completed |
Fred Hutchinson Cancer Research Center |
2006-11-30 |
| NCT00408681 |
Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00408681 |
Completed |
Fred Hutchinson Cancer Research Center |
2010-11-30 |
| NCT00397813 |
Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders |
https://ClinicalTrials.gov/show/NCT00397813 |
Completed |
Fred Hutchinson Cancer Research Center |
2017-09-30 |
| NCT00799461 |
Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications |
https://ClinicalTrials.gov/show/NCT00799461 |
Completed |
Fred Hutchinson Cancer Research Center |
2011-11-30 |
| NCT00381550 |
3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia |
https://ClinicalTrials.gov/show/NCT00381550 |
Completed |
National Cancer Institute (NCI) |
2011-03-31 |
| NCT00376922 |
Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases |
https://ClinicalTrials.gov/show/NCT00376922 |
Completed |
Wake Forest University Health Sciences |
2007-05-31 |
| NCT00361140 |
Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT) |
https://ClinicalTrials.gov/show/NCT00361140 |
Completed |
H. Lee Moffitt Cancer Center and Research Institute |
2012-02-29 |
| NCT00357708 |
Vorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer or Other Diseases |
https://ClinicalTrials.gov/show/NCT00357708 |
Completed |
National Cancer Institute (NCI) |
2009-10-31 |
| NCT00357305 |
Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders |
https://ClinicalTrials.gov/show/NCT00357305 |
Completed |
National Cancer Institute (NCI) |
2011-11-30 |
| NCT00351975 |
Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases |
https://ClinicalTrials.gov/show/NCT00351975 |
Completed |
National Cancer Institute (NCI) |
2013-03-31 |
| NCT00346359 |
Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer |
https://ClinicalTrials.gov/show/NCT00346359 |
Completed |
Fred Hutchinson Cancer Research Center |
NA |
| NCT00331513 |
Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes |
https://ClinicalTrials.gov/show/NCT00331513 |
Completed |
National Cancer Institute (NCI) |
2010-01-31 |
| NCT00322101 |
Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia |
https://ClinicalTrials.gov/show/NCT00322101 |
Completed |
Fred Hutchinson Cancer Research Center |
2012-04-30 |
| NCT00305682 |
Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant |
https://ClinicalTrials.gov/show/NCT00305682 |
Active, not recruiting |
Masonic Cancer Center, University of Minnesota |
2020-06-30 |
| NCT00301938 |
7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes |
https://ClinicalTrials.gov/show/NCT00301938 |
Completed |
National Cancer Institute (NCI) |
2012-05-31 |
| NCT00296023 |
Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00296023 |
Completed |
University of California, San Francisco |
2007-06-30 |
| NCT00293410 |
Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders |
https://ClinicalTrials.gov/show/NCT00293410 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2010-04-30 |
| NCT00293384 |
Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00293384 |
Completed |
Barbara Ann Karmanos Cancer Institute |
2009-06-30 |
| NCT00290641 |
Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00290641 |
Completed |
Masonic Cancer Center, University of Minnesota |
2006-01-31 |
| NCT00283114 |
A Safety Study of Lintuzumab in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00283114 |
Completed |
Seattle Genetics, Inc. |
2010-01-31 |
| NCT00274820 |
Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder |
https://ClinicalTrials.gov/show/NCT00274820 |
Completed |
Case Comprehensive Cancer Center |
2007-09-30 |
| NCT00265837 |
Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00265837 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2007-08-31 |
| NCT00255710 |
Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00255710 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
NA |
| NCT00245037 |
Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00245037 |
Completed |
OHSU Knight Cancer Institute |
2015-08-31 |
| NCT00217386 |
Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes |
https://ClinicalTrials.gov/show/NCT00217386 |
Completed |
Fred Hutchinson Cancer Research Center |
2007-12-31 |
| NCT00186576 |
Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders |
https://ClinicalTrials.gov/show/NCT00186576 |
Completed |
Stanford University |
2004-03-31 |
| NCT00186342 |
Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT00186342 |
Completed |
Stanford University |
2009-01-31 |
| NCT00185796 |
TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD |
https://ClinicalTrials.gov/show/NCT00185796 |
Completed |
Stanford University |
2014-04-30 |
| NCT00175838 |
Primary Thrombocythaemia 1 Trial |
https://ClinicalTrials.gov/show/NCT00175838 |
Completed |
University of Cambridge |
2016-11-30 |
| NCT00146055 |
Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood |
https://ClinicalTrials.gov/show/NCT00146055 |
Completed |
University of Michigan Rogel Cancer Center |
2004-11-30 |
| NCT00134017 |
Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00134017 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2010-02-28 |
| NCT00134004 |
Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00134004 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2015-01-31 |
| NCT00132015 |
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis |
https://ClinicalTrials.gov/show/NCT00132015 |
Completed |
National Institutes of Health Clinical Center (CC) |
2007-12-31 |
| NCT00118352 |
Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00118352 |
Completed |
Fred Hutchinson Cancer Research Center |
2010-07-31 |
| NCT00114257 |
Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders |
https://ClinicalTrials.gov/show/NCT00114257 |
Completed |
National Cancer Institute (NCI) |
2006-09-30 |
| NCT00112593 |
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer |
https://ClinicalTrials.gov/show/NCT00112593 |
Completed |
Fred Hutchinson Cancer Research Center |
2014-11-30 |
| NCT00109993 |
Campath-1H + FK506 and Methylprednisolone for GVHD |
https://ClinicalTrials.gov/show/NCT00109993 |
Completed |
Case Comprehensive Cancer Center |
2006-06-30 |
| NCT00105001 |
Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00105001 |
Completed |
Fred Hutchinson Cancer Research Center |
2011-05-31 |
| NCT00104975 |
Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00104975 |
Completed |
Yale University |
2008-05-31 |
| NCT00104923 |
Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00104923 |
Completed |
California Cancer Consortium |
2017-04-30 |
| NCT00098683 |
Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes |
https://ClinicalTrials.gov/show/NCT00098683 |
Completed |
Children’s Oncology Group |
2007-10-31 |
| NCT00096161 |
Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00096161 |
Completed |
Fred Hutchinson Cancer Research Center |
2015-02-28 |
| NCT00096096 |
Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT00096096 |
Completed |
Fred Hutchinson Cancer Research Center |
2006-05-31 |
| NCT00093366 |
Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes |
https://ClinicalTrials.gov/show/NCT00093366 |
Completed |
Fred Hutchinson Cancer Research Center |
NA |
| NCT00003451 |
Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer |
https://ClinicalTrials.gov/show/NCT00003451 |
Completed |
National Cancer Institute (NCI) |
2001-12-31 |
| NCT00003331 |
Combination Chemotherapy in Treating Patients With Advanced Cancer |
https://ClinicalTrials.gov/show/NCT00003331 |
Completed |
NYU Langone Health |
2001-11-30 |
| NCT00002980 |
Decitabine in Treating Patients With Melanoma or Other Advanced Cancer |
https://ClinicalTrials.gov/show/NCT00002980 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00003406 |
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer |
https://ClinicalTrials.gov/show/NCT00003406 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00002742 |
Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00002742 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00089037 |
Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT00089037 |
Completed |
Fred Hutchinson Cancer Research Center |
2005-04-30 |
| NCT00005805 |
St. John’s Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer |
https://ClinicalTrials.gov/show/NCT00005805 |
Completed |
Memorial Sloan Kettering Cancer Center |
2000-06-30 |
| NCT00004258 |
EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer |
https://ClinicalTrials.gov/show/NCT00004258 |
Completed |
Indiana University |
2001-08-31 |
| NCT00002504 |
Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer |
https://ClinicalTrials.gov/show/NCT00002504 |
Completed |
Hoag Memorial Hospital Presbyterian |
1998-02-28 |
| NCT00003082 |
Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer |
https://ClinicalTrials.gov/show/NCT00003082 |
Completed |
University of Arizona |
2001-02-28 |
| NCT00006251 |
Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer |
https://ClinicalTrials.gov/show/NCT00006251 |
Completed |
Fred Hutchinson Cancer Research Center |
2005-09-30 |
| NCT00006083 |
Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter |
https://ClinicalTrials.gov/show/NCT00006083 |
Completed |
Jonsson Comprehensive Cancer Center |
2000-11-30 |
| NCT00082654 |
Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients |
https://ClinicalTrials.gov/show/NCT00082654 |
Completed |
Fred Hutchinson Cancer Research Center |
2004-10-31 |
| NCT00083187 |
VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia |
https://ClinicalTrials.gov/show/NCT00083187 |
Completed |
National Cancer Institute (NCI) |
2007-01-31 |
| NCT00003887 |
Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT00003887 |
Completed |
Fred Hutchinson Cancer Research Center |
NA |
| NCT00003619 |
Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT00003619 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00010283 |
Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon |
https://ClinicalTrials.gov/show/NCT00010283 |
Completed |
Fred Hutchinson Cancer Research Center |
2002-07-31 |
| NCT00080925 |
T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT00080925 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00003107 |
Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors |
https://ClinicalTrials.gov/show/NCT00003107 |
Completed |
Indiana University |
NA |
| NCT00006348 |
Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment |
https://ClinicalTrials.gov/show/NCT00006348 |
Completed |
Alliance for Clinical Trials in Oncology |
2001-09-30 |
| NCT00078858 |
Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00078858 |
Completed |
Fred Hutchinson Cancer Research Center |
2006-01-31 |
| NCT00004904 |
Stem Cell Transplantation in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00004904 |
Completed |
Northwestern University |
2000-07-31 |
| NCT00003600 |
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy |
https://ClinicalTrials.gov/show/NCT00003600 |
Completed |
Alliance for Clinical Trials in Oncology |
2001-12-31 |
| NCT00077558 |
3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00077558 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
NA |
| NCT00075816 |
Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) |
https://ClinicalTrials.gov/show/NCT00075816 |
Completed |
Medical College of Wisconsin |
2013-04-30 |
| NCT00075478 |
Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00075478 |
Completed |
Fred Hutchinson Cancer Research Center |
2014-02-28 |
| NCT00006367 |
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis |
https://ClinicalTrials.gov/show/NCT00006367 |
Completed |
Fred Hutchinson Cancer Research Center |
NA |
| NCT00072475 |
Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes |
https://ClinicalTrials.gov/show/NCT00072475 |
Completed |
Alliance for Clinical Trials in Oncology |
2008-11-30 |
| NCT00068523 |
Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT00068523 |
Completed |
Case Comprehensive Cancer Center |
2004-03-31 |
| NCT00068276 |
Cholecalciferol in Treating Patients With Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00068276 |
Completed |
Wake Forest University Health Sciences |
2005-06-30 |
| NCT00005804 |
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00005804 |
Completed |
Fred Hutchinson Cancer Research Center |
2002-08-31 |
| NCT00066599 |
Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy |
https://ClinicalTrials.gov/show/NCT00066599 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00066248 |
Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment |
https://ClinicalTrials.gov/show/NCT00066248 |
Completed |
University of South Florida |
2007-08-31 |
| NCT00064311 |
Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT00064311 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00003913 |
Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease |
https://ClinicalTrials.gov/show/NCT00003913 |
Completed |
Fred Hutchinson Cancer Research Center |
2005-08-31 |
| NCT00064090 |
3-AP and Cytarabine in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00064090 |
Completed |
National Cancer Institute (NCI) |
2004-09-30 |
| NCT00042900 |
Pyroxamide in Treating Patients With Advanced Cancer |
https://ClinicalTrials.gov/show/NCT00042900 |
Completed |
Memorial Sloan Kettering Cancer Center |
2002-09-30 |
| NCT00062140 |
Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00062140 |
Completed |
Fred Hutchinson Cancer Research Center |
NA |
| NCT00061581 |
Experimental Bone Marrow Transplant Protocol |
https://ClinicalTrials.gov/show/NCT00061581 |
Completed |
National Institutes of Health Clinical Center (CC) |
2007-12-28 |
| NCT00003408 |
Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer |
https://ClinicalTrials.gov/show/NCT00003408 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00004232 |
Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00004232 |
Completed |
Northwestern University |
2002-10-31 |
| NCT00006225 |
Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00006225 |
Completed |
Northwestern University |
2004-01-31 |
| NCT00055653 |
Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders |
https://ClinicalTrials.gov/show/NCT00055653 |
Completed |
Roswell Park Cancer Institute |
2003-09-30 |
| NCT00054340 |
Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder |
https://ClinicalTrials.gov/show/NCT00054340 |
Completed |
Fred Hutchinson Cancer Research Center |
NA |
| NCT00054327 |
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00054327 |
Completed |
Case Comprehensive Cancer Center |
2011-09-30 |
| NCT00054236 |
Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT00054236 |
Completed |
Case Comprehensive Cancer Center |
2011-03-31 |
| NCT00053989 |
NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders |
https://ClinicalTrials.gov/show/NCT00053989 |
Completed |
Roswell Park Cancer Institute |
2018-07-19 |
| NCT00053287 |
Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS |
https://ClinicalTrials.gov/show/NCT00053287 |
Completed |
Case Comprehensive Cancer Center |
2007-01-31 |
| NCT00053196 |
Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00053196 |
Completed |
Alliance for Clinical Trials in Oncology |
2006-11-30 |
| NCT00053157 |
Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT00053157 |
Completed |
Roswell Park Cancer Institute |
2004-08-31 |
| NCT00053001 |
Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00053001 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00052832 |
Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia |
https://ClinicalTrials.gov/show/NCT00052832 |
Completed |
University of Wisconsin, Madison |
2005-07-31 |
| NCT00049686 |
VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00049686 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00049634 |
Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder |
https://ClinicalTrials.gov/show/NCT00049634 |
Completed |
Fred Hutchinson Cancer Research Center |
2007-02-28 |
| NCT00045305 |
Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes |
https://ClinicalTrials.gov/show/NCT00045305 |
Completed |
Eastern Cooperative Oncology Group |
2014-02-28 |
| NCT00044954 |
Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00044954 |
Completed |
University of Texas Southwestern Medical Center |
2006-11-30 |
| NCT00042822 |
FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin’s Lymphoma |
https://ClinicalTrials.gov/show/NCT00042822 |
Completed |
National Cancer Institute (NCI) |
2005-03-31 |
| NCT00040846 |
Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies |
https://ClinicalTrials.gov/show/NCT00040846 |
Completed |
Fred Hutchinson Cancer Research Center |
2009-12-31 |
| NCT00036790 |
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer |
https://ClinicalTrials.gov/show/NCT00036790 |
Completed |
University of Wisconsin, Madison |
2005-10-31 |
| NCT00030550 |
Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00030550 |
Completed |
Roswell Park Cancer Institute |
2003-06-30 |
| NCT00028730 |
Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00028730 |
Completed |
Memorial Sloan Kettering Cancer Center |
2006-07-31 |
| NCT00027560 |
Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00027560 |
Completed |
Memorial Sloan Kettering Cancer Center |
2009-04-30 |
| NCT00025415 |
Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction |
https://ClinicalTrials.gov/show/NCT00025415 |
Completed |
National Cancer Institute (NCI) |
2005-01-31 |
| NCT00022048 |
Bevacizumab in Treating Patients With Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00022048 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00019656 |
Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00019656 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00795769 |
Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00795769 |
Completed |
Fred Hutchinson Cancer Research Center |
2009-06-09 |
| NCT00015925 |
MS-275 in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00015925 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
NA |
| NCT00014495 |
Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer |
https://ClinicalTrials.gov/show/NCT00014495 |
Completed |
Memorial Sloan Kettering Cancer Center |
2009-12-31 |
| NCT00014482 |
Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT00014482 |
Completed |
Memorial Sloan Kettering Cancer Center |
2003-03-31 |
| NCT00014469 |
Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00014469 |
Completed |
Memorial Sloan Kettering Cancer Center |
2007-05-31 |
| NCT00014235 |
Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT00014235 |
Completed |
Fred Hutchinson Cancer Research Center |
2005-02-28 |
| NCT00006379 |
Non-Ablative Allo HSCT For Hematologic Malignancies or SAA |
https://ClinicalTrials.gov/show/NCT00006379 |
Completed |
Case Comprehensive Cancer Center |
2004-01-31 |
| NCT00006239 |
Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00006239 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2005-02-28 |
| NCT00006042 |
Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00006042 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
NA |
| NCT00006040 |
Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia |
https://ClinicalTrials.gov/show/NCT00006040 |
Completed |
Memorial Sloan Kettering Cancer Center |
2003-11-30 |
| NCT00005967 |
Tipifarnib in Treating Patients With Advanced Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00005967 |
Completed |
National Cancer Institute (NCI) |
2004-04-30 |
| NCT00005863 |
Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT00005863 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00005823 |
Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00005823 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00005797 |
Bone Marrow Transplant in Treating Patients With Hematologic Cancers |
https://ClinicalTrials.gov/show/NCT00005797 |
Completed |
H. Lee Moffitt Cancer Center and Research Institute |
2007-07-31 |
| NCT00005622 |
Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders |
https://ClinicalTrials.gov/show/NCT00005622 |
Completed |
H. Lee Moffitt Cancer Center and Research Institute |
2005-09-30 |
| NCT00004899 |
Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00004899 |
Completed |
Northwestern University |
2004-08-31 |
| NCT00004896 |
Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00004896 |
Completed |
Northwestern University |
2004-08-31 |
| NCT00004871 |
Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00004871 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
NA |
| NCT00004245 |
Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT00004245 |
Completed |
Memorial Sloan Kettering Cancer Center |
2004-09-30 |
| NCT00004181 |
Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia |
https://ClinicalTrials.gov/show/NCT00004181 |
Completed |
Northwestern University |
2004-08-31 |
| NCT00003961 |
Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00003961 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2007-12-31 |
| NCT00003687 |
Treatment for Chronic Pain in Patients With Advanced Cancer |
https://ClinicalTrials.gov/show/NCT00003687 |
Completed |
Canadian Cancer Trials Group |
2001-09-26 |
| NCT00003593 |
Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00003593 |
Completed |
Children’s Oncology Group |
2007-03-31 |
| NCT00003336 |
Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions |
https://ClinicalTrials.gov/show/NCT00003336 |
Completed |
Case Comprehensive Cancer Center |
2005-12-31 |
| NCT00003335 |
Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00003335 |
Completed |
Case Comprehensive Cancer Center |
2007-11-30 |
| NCT00003243 |
Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00003243 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
NA |
| NCT00003116 |
High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00003116 |
Completed |
Case Comprehensive Cancer Center |
2006-03-31 |
| NCT00002809 |
Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00002809 |
Completed |
Temple University |
2003-12-31 |
| NCT00002792 |
Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders |
https://ClinicalTrials.gov/show/NCT00002792 |
Completed |
Fred Hutchinson Cancer Research Center |
2003-04-30 |
| NCT00002718 |
T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT00002718 |
Completed |
Memorial Sloan Kettering Cancer Center |
2004-01-31 |
| NCT00038051 |
Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies |
https://ClinicalTrials.gov/show/NCT00038051 |
Completed |
M.D. Anderson Cancer Center |
2013-02-28 |
| NCT00003816 |
Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00003816 |
Completed |
Roswell Park Cancer Institute |
2019-07-12 |
| NCT00002746 |
Interleukin-2 in Treating Patients With Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00002746 |
Completed |
University of Washington |
2004-04-30 |